2,491
Views
30
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis

, &
Pages 997-1001 | Received 01 Dec 2014, Accepted 08 Jan 2015, Published online: 14 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Carmen L. Zegarra-Urquia, Julio Santiago, Joel D. Bumgardner, Alexander K. Goroncy, José Vega-Baudrit, Claudia A. Hernández-Escobar & E. Armando Zaragoza-Contreras. (2024) Characterization of isoniazid incorporation into chitosan-poly(aspartic acid) nanoparticles. International Journal of Polymeric Materials and Polymeric Biomaterials 73:3, pages 190-199.
Read now
Bruna Ortolani Turco, Fernanda Isadora Boni, Maria Palmira Daflon Gremião & Marlus Chorilli. (2021) Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis. Drug Development and Industrial Pharmacy 47:12, pages 1904-1914.
Read now
Kai Berkenfeld, Jason T. McConville & Alf Lamprecht. (2020) Inhalable dry powders of rifampicin highlighting potential and drawbacks in formulation development for experimental tuberculosis aerosol therapy. Expert Opinion on Drug Delivery 17:3, pages 305-322.
Read now
Flavio De Maio, Valentina Palmieri, Marco De Spirito, Giovanni Delogu & Massimiliano Papi. (2019) Carbon nanomaterials: a new way against tuberculosis. Expert Review of Medical Devices 16:10, pages 863-875.
Read now
Sweet Naskar, Ketousetuo Kuotsu & Suraj Sharma. (2019) Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research. Journal of Drug Targeting 27:4, pages 379-393.
Read now
Saeideh Abdolahpour, Tayebeh Toliyat, Kobra Omidfar, Helmout Modjtahedi, Albert J. Wong, Mohammad Javad Rasaee, Susan Kashanian & Maliheh Paknejad. (2018) Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody. Artificial Cells, Nanomedicine, and Biotechnology 46:1, pages 89-94.
Read now
Baljeet Singh, Tarun Garg, Amit K. Goyal & Goutam Rath. (2016) Development, optimization, and characterization of polymeric electrospun nanofiber: a new attempt in sublingual delivery of nicorandil for the management of angina pectoris. Artificial Cells, Nanomedicine, and Biotechnology 44:6, pages 1498-1507.
Read now
Tarun Garg, Saurav Bhandari, Goutam Rath & Amit K. Goyal. (2015) Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor. Journal of Drug Targeting 23:10, pages 865-887.
Read now

Articles from other publishers (21)

Eknath Kole, Krishna Jadhav, Nitin Shirsath, Prashik Dudhe, Rahul K. Verma, Aniruddha Chatterjee & Jitendra Naik. (2023) Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases. Journal of Drug Delivery Science and Technology 81, pages 104261.
Crossref
Piyush Pradeep Mehta & Vividha Dhapte-Pawar. 2023. Pulmonary Drug Delivery Systems: Material and Technological Advances. Pulmonary Drug Delivery Systems: Material and Technological Advances 213 245 .
Sanjoy Kumar Das, Soumalya Chakraborty, Sourav Bhowmik, Sudipta Roy & Yashwant Pathak. 2023. Tubercular Drug Delivery Systems. Tubercular Drug Delivery Systems 79 97 .
Kiran Dudhat & Harsha Patel. (2022) Preparation and evaluation of pirfenidone loaded chitosan nanoparticles pulmonary delivery for idiopathic pulmonary fibrosis. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Irina M. Le-Deygen, Viktoria V. Rokosovina, Anna A. Skuredina, Ivan D. Yakimov & Elena V. Kudryashova. (2022) The Charge and Phase State of Liposomes Dramatically Affects the Binding of Mannosylated Chitosan. Future Pharmacology 2:3, pages 330-346.
Crossref
Joandra Maísa da Silva Leite, Yuri Basilio Gomes Patriota, Mônica Felts de La Roca & José Lamartine Soares-Sobrinho. (2022) New Perspectives in Drug Delivery Systems for the Treatment of Tuberculosis. Current Medicinal Chemistry 29:11, pages 1936-1958.
Crossref
Amarjitsing Rajput, Satish Mandlik & Varsha Pokharkar. (2021) Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis. Frontiers in Pharmacology 12.
Crossref
M. E. F. A. G. Oliveira, Y. J. A. Silva, L. A. Azevedo, L. A. Linhares, L. M. L. Montenegro, S AlvesJrJr & R. V. S. Amorim. (2021) Antimycobacterial compound of chitosan and ethambutol: ultrastructural biological evaluation in vitro against Mycobacterium tuberculosis. Applied Microbiology and Biotechnology 105:24, pages 9167-9179.
Crossref
Janela Rose Agpangan Limocon, Lyka Marie Cawaling Madalag, Paulyn Jade Balungcas Reliquias, Janina Veana Soriano Tionko, Jamie Ledesma Fermin, Shaira Limson Kee, Myles Joshua Toledo Tan, Maria J-len Juesna Jonco & Ma. Junallie Fuentebella Pomperada. (2021) Small but Terrible: Utilizing Chitosan-Based Nanoparticles as Drug Carriers to Treat Tuberculosis in the Philippines. Frontiers in Pharmacology 12.
Crossref
Sunny Shah, Rohit Ghetiya, Moinuddin Soniwala & Jayant Chavda. (2021) Development and Optimization of Inhalable Levofloxacin Nanoparticles for The Treatment of Tuberculosis. Current Drug Delivery 18:6, pages 779-793.
Crossref
Nehal A. Salahuddin, M. Ali, Hamad A. Al-Lohedan, Zuheir A. Issa, Assem Barakat & Mohamad M. Ayad. (2021) Aniline- co - o -anthranilic Acid Copolymer-Chitosan/Ag@AgCl Nanohybrid as a Carrier for ( E )- N ′-(Pyridin-2-ylmethylene) Hydrazinecarbothiohydrazide Release and Antimicrobial Activity . ACS Omega 6:34, pages 21939-21951.
Crossref
Goutam Rath, Deepak Pradhan, Goutam Ghosh & Amit K. Goyal. (2021) Challenges and Opportunities of Nanotechnological based Approach for the Treatment of Tuberculosis. Current Pharmaceutical Design 27:17, pages 2026-2040.
Crossref
Iyyakkannu Sivanesan, Manikandan Muthu, Judy Gopal, Nazim Hasan, Syed Kashif Ali, Juhyun Shin & Jae-Wook Oh. (2021) Nanochitosan: Commemorating the Metamorphosis of an ExoSkeletal Waste to a Versatile Nutraceutical. Nanomaterials 11:3, pages 821.
Crossref
Adam S Mullis, Nathan Peroutka-Bigus, Kruttika S Phadke, Bryan H Bellaire & Balaji Narasimhan. (2021) Nanomedicines to counter microbial barriers and antimicrobial resistance. Current Opinion in Chemical Engineering 31, pages 100672.
Crossref
Ruhisy Mohd Rasul, M. Tamilarasi Muniandy, Zabliza Zakaria, Kifayatullah Shah, Chin Fei Chee, Ali Dabbagh, Noorsaadah Abd Rahman & Tin Wui Wong. (2020) A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers. Carbohydrate Polymers 250, pages 116800.
Crossref
Aram dokht khatibi Khatibi, Zarrin EshaghiHamid MosaddeghiDavoud Balarak. (2020) Molecular Dynamics Simulation, Characterization and In Vitro Drug Release of Isoniazid Loaded Poly-ε-caprolactone Magnetite Nanocomposite. Pharmaceutical Sciences 26:4, pages 406-413.
Crossref
Letícia C. Assis, Nerilson M. Lima, Teresinha J. A. S. Andrade, Patricia H. Y. Cordeiro, Carlton A. Taft & Felipe de Almeida La Porta. 2020. Emerging Research in Science and Engineering Based on Advanced Experimental and Computational Strategies. Emerging Research in Science and Engineering Based on Advanced Experimental and Computational Strategies 107 143 .
Ting Wu, Weiping Liao, Wei Wang, Jie Zhou, Weiguo Tan, Weibing Xiang, Jinglin Zhang, Lina Guo, Tao Chen, Dong Ma, Weiye Yu & Xiang Cai. (2018) Genipin-crosslinked carboxymethyl chitosan nanogel for lung-targeted delivery of isoniazid and rifampin. Carbohydrate Polymers 197, pages 403-413.
Crossref
Arunachalam Muthuraman. 2018. Nanostructures for the Engineering of Cells, Tissues and Organs. Nanostructures for the Engineering of Cells, Tissues and Organs 105 154 .
G. Conzatti, D. Faucon, M. Castel, F. Ayadi, S. Cavalie & A. Tourrette. (2017) Alginate/chitosan polyelectrolyte complexes: A comparative study of the influence of the drying step on physicochemical properties. Carbohydrate Polymers 172, pages 142-151.
Crossref
Arunachalam Muthuraman & Jaspreet Kaur. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy 139 167 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.